SAGE | Sage Therapeutics Inc
Category: Consumer goods
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 1.91B Prev closed: Open: 31.04 High: 31.95 Low: 30.8 52 week low: 30.48 52 week high: 81.98 Dividends: No Dividends Next ER: February 16, 2023 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast May 4, 2023 February 16, 2023 -2.47 / -2.372.87M / 1.95MBeat! November 8, 2022 -2.31 / -2.221.74M / 1.68MBeat! August 2, 2022 -2.13 / -2.131.5M / 1.76MMay 3, 2022 -2.07 / -2.061.58M / 3.23Mview more
Historical Data Date Price Open High Low Vol Change ER Aug 2, 2022 35.26 34.32 36.46
33.88
391.34K 2.26% Aug 1, 2022 34.48 34.21 34.73
33.83
675.23K 0.20% Jul 29, 2022 34.41 34.72 34.72
33.87
412.09K -1.21% Jul 28, 2022 34.83 34.76 35.20
33.74
437.08K 0.40% Jul 27, 2022 34.69 34.53 35.14
33.95
360.94K 0.55% Jul 26, 2022 34.50 34.10 35.17
33.81
340.74K 0.52% Jul 25, 2022 34.32 34.82 34.82
33.92
236.00K -1.29% Jul 22, 2022 34.77 35.65 35.89
34.23
562.96K -2.28% Jul 21, 2022 35.58 36.53 36.67
35.43
354.41K -2.65% Jul 20, 2022 36.55 36.06 37.37
35.63
802.11K 1.81% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2010 Employees:637 News
Why Sage Therapeutics Stock Is Crashing Today fool.com Mar 14, 2023 12:17 pm
Sage Therapeutics (SAGE) Depression Drug Meets Goal, Stock Down finance.yahoo.com Mar 14, 2023 11:28 am Sage's stock falls 11% on new clinical data for experimental depression drug marketwatch.com Mar 14, 2023 8:33 am FDA grants Priority Review to depression drug; Sages stock rallies finance.yahoo.com Mar 14, 2023 8:20 am Sage, Biogen start 'rolling submission' to FDA for depression drug marketwatch.com Mar 14, 2023 7:52 am
Sage Therapeutics, Inc. (SAGE) Reports Q4 Loss, Misses Revenue Estimates finance.yahoo.com Mar 14, 2023 7:45 am Sage's depression drug improves symptoms, but durability concerns sink shares finance.yahoo.com Mar 14, 2023 7:40 am
Sage Therapeutics and Biogen Announce the Phase 3 CORAL Study Met its Primary and Key Secondary Endpoints - Comparing Zuranolone 50 mg Co-initiated with Standard of Care Antidepressant vs. Standard of Care Co-initiated with Placebo in People with MDD finance.yahoo.com Mar 14, 2023 7:00 am UPDATE 2-Sage-Biogen drug improves symptoms in postpartum depression study finance.yahoo.com Mar 14, 2023 6:50 am
Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeline and Business Progress finance.yahoo.com Mar 14, 2023 6:30 am
Sage Therapeutics Announces Third Quarter 2022 Financial Results and Highlights Pipeline and Business Progress finance.yahoo.com Mar 14, 2023 6:30 am
Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression finance.yahoo.com Mar 14, 2023 6:30 am
Sage Therapeutics, Inc. (SAGE) Soars 9.6%: Is Further Upside Left in the Stock? finance.yahoo.com Mar 14, 2023 3:43 am
Strength Seen in Revolution Medicines, Inc. (RVMD): Can Its 15.9% Jump Turn into More Strength? finance.yahoo.com Jan 12, 2023 3:25 am
Sage Therapeutics (NASDAQ:SAGE) shareholders are up 5.6% this past week, but still in the red over the last five years finance.yahoo.com Jan 7, 2023 9:21 am
An Intrinsic Calculation For Sage Therapeutics, Inc. (NASDAQ:SAGE) Suggests It's 31% Undervalued finance.yahoo.com Dec 7, 2022 12:36 pm
President Barry Greene Just Bought 45% More Shares In Sage Therapeutics, Inc. (NASDAQ:SAGE) finance.yahoo.com Nov 17, 2022 5:03 am
Sage Therapeutics to Present at the Stifel 2022 Healthcare Conference finance.yahoo.com Nov 9, 2022 6:30 am
Sage Therapeutics/Biogen Highlight Additional Data From Depression Candidate finance.yahoo.com Oct 17, 2022 10:49 am Sage Therapeutics Stock Scores Relative Strength Rating Upgrade investors.com Sep 9, 2022 2:50 pm This company doesn't provide a dividend.
Key Persons Talk about Sage Therapeutics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 47 HOLD 53 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology